placeholder
NOTABLE68
COMMERCIALLimited grounding
PwC cuts weight-loss drugs from employee health benefits - The Times
PwC removed weight-loss drugs from its employee health insurance coverage. The move signals employer caution about the cost and use of these medications for workers.
Analysis
PwC dropping GLP-1 coverage adds to the employer-pushback narrative, a key overhang on commercial GLP-1 volume growth for Lilly and Novo.
- PwC removed weight-loss drugs from employee health insurance coverage
- Move reflects employer concerns over cost of these medications
Semaglutide News2d
Read